THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Shannon Conley to Genetic Vectors

This is a "connection" page, showing publications Shannon Conley has written about Genetic Vectors.
Connection Strength

0.663
  1. Nonviral ocular gene therapy: assessment and future directions. Curr Opin Mol Ther. 2008 Oct; 10(5):456-63.
    View in: PubMed
    Score: 0.306
  2. Characterization of Ribozymes Targeting a Congenital Night Blindness Mutation in Rhodopsin Mutation. Adv Exp Med Biol. 2016; 854:509-15.
    View in: PubMed
    Score: 0.126
  3. Comparative analysis of DNA nanoparticles and AAVs for ocular gene delivery. PLoS One. 2012; 7(12):e52189.
    View in: PubMed
    Score: 0.102
  4. AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects. Invest Ophthalmol Vis Sci. 2011 May 10; 52(6):3051-9.
    View in: PubMed
    Score: 0.092
  5. Aquaporin-1 expression and conventional aqueous outflow in human eyes. Exp Eye Res. 2008 Oct; 87(4):349-55.
    View in: PubMed
    Score: 0.019
  6. Nanoparticle applications in ocular gene therapy. Vision Res. 2008 Feb; 48(3):319-24.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES